Diverse Biotech Names Dr. Sarah Katta as Medical Director

April 2nd, 2018 | Highly Respected Orlando Cancer Doctor to Become Medical Director

Diverse Biotech is extremely pleased to announce the execution of a Medical Director Agreement withDr. Sarah Katta of Southwest Cancer Center in Orlando Florida.

Since insurance doesn’t cover cannabinoids, oncology patients who are less fortunate and under Southwest Cancer Centers care may receive pro-bono bottles, under the “Karenna” program. The Karenna program allows for a certain percentage of bottles to be given at no cost to patients, at the discretion of the doctors at that location.

Dr. Sarah Katta, commented, “I’m truly honored to be a part of such a groundbreaking research organization. The level of excellence and experience at Diverse Biotech makes me proud to be involved. I have personally seen what cannabinoids can do for patients who have very little hope otherwise and I am excited.”

“Dr. Sarah is highly respected oncologist and we are proud to have her on-board.” said Diverse Biotechs’ Board Member, Beaudon Spaulding.

Southwest Cancer Center was established by Dr. Thomas Katta in 1984 and has been serving Orlando for 33 years. They specialize in Hematology/Oncology and are one of the highest rated practices in the region. There are five doctors and two locations in Orlando and they serve thousands of patients, 922 Lucerne Terrace Orlando FL 32806 and 7436 Docs Grove Circle, Orlando, FL 32819.